var data={"title":"Mansonella infections","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Mansonella infections</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/mansonella-infections/contributors\" class=\"contributor contributor_credentials\">Amy D Klion, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/mansonella-infections/contributors\" class=\"contributor contributor_credentials\">Peter F Weller, MD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/mansonella-infections/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/mansonella-infections/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 26, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H4462369\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Three species of <em>Mansonella</em> cause human infections: <em>M. streptocerca</em>, <em>M. perstans</em>, and <em>M. ozzardi</em>. Each species has a limited geographic distribution and typically causes mild symptoms if any at all.</p><p>The epidemiology, clinical features, diagnosis, and treatment of <em>Mansonella</em> infections will be reviewed here (<a href=\"image.htm?imageKey=ID%2F66052%7EID%2F70668\" class=\"graphic graphic_table graphicRef66052 graphicRef70668 \">table 1A-B</a>). Other filarial infections, including loiasis, onchocerciasis, and lymphatic filariasis, are discussed separately. (See <a href=\"topic.htm?path=onchocerciasis\" class=\"medical medical_review\">&quot;Onchocerciasis&quot;</a> and <a href=\"topic.htm?path=lymphatic-filariasis-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Lymphatic filariasis: Epidemiology, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=lymphatic-filariasis-treatment-and-prevention\" class=\"medical medical_review\">&quot;Lymphatic filariasis: Treatment and prevention&quot;</a> and <a href=\"topic.htm?path=loiasis-loa-loa-infection\" class=\"medical medical_review\">&quot;Loiasis (Loa loa infection)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4462376\"><span class=\"h1\">MANSONELLA PERSTANS</span></p><p class=\"headingAnchor\" id=\"H4462384\"><span class=\"h2\">Epidemiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>M. perstans</em> is endemic in a large portion of sub-Saharan Africa, from Senegal to Uganda and south to Zimbabwe, and in Central and South America, from Panama to Argentina (<a href=\"image.htm?imageKey=ID%2F101816\" class=\"graphic graphic_figure graphicRef101816 \">figure 1</a> and <a href=\"image.htm?imageKey=ID%2F101817\" class=\"graphic graphic_figure graphicRef101817 \">figure 2</a>) [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/1\" class=\"abstract_t\">1</a>]. Since the majority of infected individuals are asymptomatic and diagnosis is typically based on morphologic examination of blood microfilariae, the epidemiology of <em>M. perstans</em> has not been clearly defined. Nevertheless, it has been estimated that 114 million people may be infected and as many as 581 million people in 33 countries are at risk for <em>M. perstans</em> infection in Africa alone [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/1\" class=\"abstract_t\">1</a>]. Of note, molecular analyses suggest that reports of atypical blood microfilariae in residents of the Amazon regions of Brazil and Peru, which were originally thought to be <em>M. perstans</em>, are actually <em>M. ozzardi</em> [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/2,3\" class=\"abstract_t\">2,3</a>]. (See <a href=\"#H4462447\" class=\"local\">'Mansonella ozzardi'</a> below.)</p><p>In endemic regions, the probability of infection increases with age, with prevalences reaching 100 percent in highly endemic areas. Infection of travelers is uncommon, but it does occur [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/4\" class=\"abstract_t\">4</a>]. Nonhuman primates are occasionally infected, but they do not appear to be a major reservoir of infection.</p><p><em>M. perstans</em> is transmitted by biting midges (<em>Culicoides</em>). The life cycle is similar to that of other filariae (<a href=\"image.htm?imageKey=ID%2F82920\" class=\"graphic graphic_figure graphicRef82920 \">figure 3</a>). Infective larvae introduced during the bite of an infected midge mature over months into adult worms. The adult worms live in the pleural, pericardial, and peritoneal cavities as well as the mesenteric, perirenal, and retroperitoneal tissues, where they produce unsheathed microfilariae that are found in the bloodstream at all times. Microfilariae are responsible for transmission of infection because they are taken up during the blood meal of the insect vector. The life cycle is completed following maturation of microfilariae into infective third-stage larvae within the midge. The lifespan of the adult worms is unknown, although microfilaria-positive cases have been reported up to 10 years after the infected individual has left the endemic area [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/5\" class=\"abstract_t\">5</a>].</p><p class=\"headingAnchor\" id=\"H4462398\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most individuals with <em>M. perstans</em> infection are asymptomatic [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/1,6\" class=\"abstract_t\">1,6</a>]. When symptoms do occur, they are predominantly related to migration of the adult worms and include transient subcutaneous swellings similar to the Calabar swellings of <em>Loa loa</em> infection, serositis (ie, pericarditis and pleuritis), and ocular symptoms (granulomatous nodules in the conjunctiva, retinal lesions, and periorbital inflammation surrounding dead adult worms). Nonspecific symptoms including pruritus, urticaria, arthralgia, abdominal pain, and fatigue have also been attributed to <em>M. perstans</em> infection. Neuropsychiatric manifestations, meningoencephalitis, and hepatitis have also been described.</p><p>Nonspecific but characteristic laboratory abnormalities include eosinophilia and elevated serum immunoglobulin (Ig)E levels.</p><p class=\"headingAnchor\" id=\"H4462405\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>M. perstans</em> infection should be suspected in an individual with an appropriate epidemiologic exposure, consistent clinical findings, <span class=\"nowrap\">and/or</span> unexplained eosinophilia. The definitive diagnosis is established by identifying the adult worm in tissues or microfilariae in the blood. Serology may also be useful.</p><p class=\"headingAnchor\" id=\"H4462412\"><span class=\"h3\">Visualizing organisms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of <em>M. perstans</em> infection can be definitively established by detecting microfilariae in a blood smear (<a href=\"image.htm?imageKey=ID%2F83928\" class=\"graphic graphic_picture graphicRef83928 \">picture 1</a>) or, rarely, by the identification of adult worms in tissue specimens. Microscopy sensitivity is increased using concentration techniques, such as Knott's concentration or Nuclepore membrane filtration. However, due to the small size of <em>M. perstans</em> microfilariae, membranes with a 3 mcm pore size are optimal.</p><p>Adult worms range in length from 3.5 to 4.5 cm for males and 5 to 8 cm for females. Both are no more than 120 mcm wide. Microfilariae of <em>M. perstans</em> are unsheathed and measure 190 to 200 mcm long in stained blood smears. A round terminal nucleus is found at the tip of the tail, which is blunted (<a href=\"image.htm?imageKey=ID%2F83928\" class=\"graphic graphic_picture graphicRef83928 \">picture 1</a>).</p><p><em>M. perstans</em> has been shown to have a weak diurnal periodicity with peak counts at 8:00 AM [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/7\" class=\"abstract_t\">7</a>]. This coincides with the feeding pattern of the vector, thereby potentiating transmission of infection. Their presence in the bloodstream at all times during the day can cause them to be mistaken for microfilariae of <em>L. loa</em> or <em>Wuchereria bancrofti</em>, filarial parasites that overlap in geographic distribution with <em>M. perstans</em>.</p><p class=\"headingAnchor\" id=\"H4462419\"><span class=\"h3\">Serology and other tests</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Serologic tests based on crude filarial antigens are positive in <em>M. perstans</em> infection but do not distinguish between active or past infection and show cross-reactivity between the different filarial species and with other nematode infections. Consequently, their utility is limited, although a negative result can exclude the possibility of infection.</p><p>A real-time polymerase chain reaction assay has been developed at the Laboratory of Parasitic Diseases, National Institutes of Health, that can detect and quantitate <em>M. perstans</em> microfilaremia [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/8\" class=\"abstract_t\">8</a>]. Assistance with serologic and other diagnostic tests is available from the United States Centers for Disease Control and Prevention (dpdx@cdc.gov) and the Laboratory of Parasitic Diseases, National Institutes of Health (301-496-5398).</p><p class=\"headingAnchor\" id=\"H942225774\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>M. perstans</em> infection is typically diagnosed in an asymptomatic patient as an incidental finding on a blood smear or during evaluation for other filarial infections. As such, the differential diagnosis is broad and includes all causes of unexplained eosinophilia. (See <a href=\"topic.htm?path=approach-to-the-patient-with-unexplained-eosinophilia\" class=\"medical medical_review\">&quot;Approach to the patient with unexplained eosinophilia&quot;</a>.)</p><p>The differential diagnosis for symptomatic presentation depends on the specific clinical manifestations. (See <a href=\"topic.htm?path=acute-pericarditis-clinical-presentation-and-diagnostic-evaluation\" class=\"medical medical_review\">&quot;Acute pericarditis: Clinical presentation and diagnostic evaluation&quot;</a> and <a href=\"topic.htm?path=diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing\" class=\"medical medical_review\">&quot;Diagnostic evaluation of a pleural effusion in adults: Initial testing&quot;</a>.)</p><p>Angioedema and eye findings can be similar to those seen in loiasis. (See <a href=\"topic.htm?path=loiasis-loa-loa-infection\" class=\"medical medical_review\">&quot;Loiasis (Loa loa infection)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4462433\"><span class=\"h2\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>M. perstans</em> is relatively resistant to standard antifilarial agents, including <a href=\"topic.htm?path=diethylcarbamazine-united-states-available-via-cdc-drug-service-investigational-drug-ind-protocol-only-drug-information\" class=\"drug drug_general\">diethylcarbamazine</a> (DEC), <a href=\"topic.htm?path=ivermectin-drug-information\" class=\"drug drug_general\">ivermectin</a>, <a href=\"topic.htm?path=albendazole-drug-information\" class=\"drug drug_general\">albendazole</a>, and <a href=\"topic.htm?path=mebendazole-drug-information\" class=\"drug drug_general\">mebendazole</a> [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/1,9\" class=\"abstract_t\">1,9</a>]. In one study that compared the efficacy of multiple regimens, the best efficacy was observed with a combination of diethylcarbamazine and mebendazole administered for 21 days (37 percent microfilarial clearance at 1 month) [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/9\" class=\"abstract_t\">9</a>].</p><p>The intracellular endosymbiont <em>Wolbachia</em> has been demonstrated in <em>M. perstans</em> from Mali and Cameroon but appears to be absent in parasites from Uganda and Gabon. <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">Doxycycline</a> (200 mg daily for six weeks), which has activity against <em>Wolbachia</em>, has been shown to be 100 percent effective in clearing <em>M. perstans</em> microfilariae from the blood of infected individuals in Mali for up to 36 months [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/10\" class=\"abstract_t\">10</a>]. The utility of doxycycline in the treatment of <em>M. perstans</em> from other geographic regions has not been explored.</p><p class=\"headingAnchor\" id=\"H4462440\"><span class=\"h2\">Prevention</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There have been no studies of chemoprophylaxis against <em>M. perstans</em> infection. Personal protection measures to limit contact with biting midges may have some utility in individual travelers. Repeated mass drug administration using <a href=\"topic.htm?path=ivermectin-drug-information\" class=\"drug drug_general\">ivermectin</a> has led to a modest decrease in prevalence in some endemic areas [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/11\" class=\"abstract_t\">11</a>].</p><p class=\"headingAnchor\" id=\"H4462447\"><span class=\"h1\">MANSONELLA OZZARDI</span></p><p class=\"headingAnchor\" id=\"H4462455\"><span class=\"h2\">Epidemiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>M. ozzardi</em> is endemic in Central America, South America (Argentina, Bolivia, Brazil, Colombia, Guyana, Suriname, and Venezuela), and the Caribbean islands (Antigua, Dominican Republic, Guadeloupe, Haiti, Martinique, Nevis, Puerto Rico, St. Kitts, St. Lucia, St. Vincent, and Trinidad). The overall prevalence of <em>M. ozzardi</em> infection is unknown; up to 70 percent of the residents in endemic foci may have parasites detectable in the blood. Infection of travelers is uncommon but does occur [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/4\" class=\"abstract_t\">4</a>]. Nonhuman primates can be infected experimentally, but humans are the only major reservoir of infection.</p><p><em>M. ozzardi</em> is transmitted by biting midges (<em>Culicoides</em>) and blackflies (<em>Simulium amazonicum</em>). The life cycle is identical to that of <em>M. perstans</em> (<a href=\"image.htm?imageKey=ID%2F83929\" class=\"graphic graphic_figure graphicRef83929 \">figure 4</a>), except that adult worms are found in the lymphatics as well as the thoracic and peritoneal cavities, and microfilariae are found both in the blood and the skin [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/12\" class=\"abstract_t\">12</a>]. The lifespan of the adult worms is unknown.</p><p class=\"headingAnchor\" id=\"H4462469\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most individuals with <em>M. ozzardi</em> infection are asymptomatic, although urticaria, pruritic skin eruptions, edema, lymphadenopathy, arthralgias, fever, headache, vertigo, and pulmonary symptoms have been reported [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/6,13\" class=\"abstract_t\">6,13</a>]. An association between <em>M. ozzardi</em> microfilaremia and nummular keratitis has also been reported in the Amazonas region of Brazil [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/14\" class=\"abstract_t\">14</a>]. Eosinophilia is common.</p><p class=\"headingAnchor\" id=\"H4462476\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>M. ozzardi</em> infection should be suspected in an individual with an appropriate epidemiologic exposure, consistent clinical findings, <span class=\"nowrap\">and/or</span> unexplained eosinophilia. The definitive diagnosis is established by identifying the microfilariae in the blood or skin. Serology may also be useful.</p><p class=\"headingAnchor\" id=\"H4462483\"><span class=\"h3\">Visualizing organisms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of <em>M. ozzardi</em> infection can be definitively established by detecting microfilariae in a blood smear (<a href=\"image.htm?imageKey=ID%2F83930\" class=\"graphic graphic_picture graphicRef83930 \">picture 2</a>) or skin snips (1 mm skin biopsies obtained using a corneoscleral punch or needle and scalpel that are incubated for 30 minutes to 24 hours in saline and examined under low magnification for the presence of motile microfilariae). Adult worms are rarely identified in tissue specimens. Concentration techniques, such as Knott's concentration or Nuclepore membrane filtration, can be useful in increasing the sensitivity of detection of blood microfilariae.</p><p>Adult female worms range in length 6.5 to 8.1 cm and up to 250 mcm wide. No intact male worms have been obtained to date. Microfilariae of <em>M. ozzardi</em> are unsheathed and measure 170 to 240 microns long in stained blood smears. They have a cephalic space that is 2 to 6 microns long with two to three overlapping nuclei and caudal space that is 3 to 8 mcm long with oval terminal nuclei (<a href=\"image.htm?imageKey=ID%2F83930\" class=\"graphic graphic_picture graphicRef83930 \">picture 2</a>).</p><p class=\"headingAnchor\" id=\"H4462490\"><span class=\"h3\">Serology and other tests</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Serologic tests based on crude filarial antigens are positive in <em>M. ozzardi</em> infection but do not distinguish between active or past infection and show cross-reactivity between the different filarial species and with other nematode infections. Consequently, their utility is limited, although a negative result can exclude the possibility of infection.</p><p>Polymerase chain reaction assays have been developed but are not routinely available outside of research laboratories. Assistance with serologic and other diagnostic tests is available from the United States Centers for Disease Control and Prevention (dpdx@cdc.gov) and the Laboratory of Parasitic Diseases, National Institutes of Health (301-496-5398).</p><p class=\"headingAnchor\" id=\"H942225827\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The rash of <em>M. ozzardi</em> infection closely resembles that of onchocerciasis, which, until recently, was coendemic in many areas in Central and South America. With the success of the Onchocerciasis Control Program, however, the only remaining areas endemic for onchocerciasis are in the remote border area between Venezuela and Brazil. (See <a href=\"topic.htm?path=onchocerciasis\" class=\"medical medical_review\">&quot;Onchocerciasis&quot;</a>.)</p><p>Most patients present with asymptomatic eosinophilia or nonspecific symptoms, including urticaria and pruritus, which have a broad differential diagnosis. (See <a href=\"topic.htm?path=approach-to-the-patient-with-unexplained-eosinophilia\" class=\"medical medical_review\">&quot;Approach to the patient with unexplained eosinophilia&quot;</a> and <a href=\"topic.htm?path=new-onset-urticaria\" class=\"medical medical_review\">&quot;New-onset urticaria&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4462504\"><span class=\"h2\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The treatment of choice for <em>M. ozzardi</em> infection is <a href=\"topic.htm?path=ivermectin-drug-information\" class=\"drug drug_general\">ivermectin</a> (200 <span class=\"nowrap\">mcg/kg</span> orally), which is effective in reducing microfilarial counts and symptoms [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/15\" class=\"abstract_t\">15</a>]. Other antifilarial therapies, including <a href=\"topic.htm?path=diethylcarbamazine-united-states-available-via-cdc-drug-service-investigational-drug-ind-protocol-only-drug-information\" class=\"drug drug_general\">diethylcarbamazine</a> and <a href=\"topic.htm?path=albendazole-drug-information\" class=\"drug drug_general\">albendazole</a> [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/16\" class=\"abstract_t\">16</a>], appear to be ineffective. Although <em>M. ozzardi</em> does harbor the intracellular endosymbiont <em>Wolbachia</em> [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/17\" class=\"abstract_t\">17</a>], there are no published studies of <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> or other antibacterial therapies to date.</p><p class=\"headingAnchor\" id=\"H4462511\"><span class=\"h2\">Prevention</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There have been no studies of chemoprophylaxis against <em>M. ozzardi</em> infection. Personal protection measures to limit contact with biting midges and blackflies may have some utility in individual travelers.</p><p class=\"headingAnchor\" id=\"H4462518\"><span class=\"h1\">MANSONELLA STREPTOCERCA</span></p><p class=\"headingAnchor\" id=\"H4462526\"><span class=\"h2\">Epidemiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>M. streptocerca</em> is endemic in the tropical rain forests of western and central Africa, including northern Angola, Cameroon, Central African Republic, Democratic Republic of Congo, Equatorial Guinea, Nigeria, People's Republic of Congo, and western Uganda. The prevalence of <em>M. streptocerca</em> infection is unknown; up to 90 percent of the residents in endemic foci may be infected. Infection of travelers is uncommon but does occur [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/4\" class=\"abstract_t\">4</a>]. Nonhuman primates are occasionally infected but do not appear to be a major reservoir of infection.</p><p>The life cycle is identical to that of <em>M. perstans</em> (<a href=\"image.htm?imageKey=ID%2F82920\" class=\"graphic graphic_figure graphicRef82920 \">figure 3</a>) except that adult worms reside in the dermis of the upper trunk and shoulder girdle and that microfilariae are found in the skin. The lifespan of the adult worms is unknown. <em>M. streptocerca</em> is transmitted by biting midges (<em>Culicoides</em>).</p><p class=\"headingAnchor\" id=\"H4462540\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most individuals with <em>M. streptocerca</em> infection are asymptomatic. The most common complaint is pruritus, especially over the shoulder girdle and thorax [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/18\" class=\"abstract_t\">18</a>]. Dermal thickening, nonanesthetic hypopigmented macules, and bilateral axillary or inguinal lymphadenopathy have been described. Unlike <em>O. volvulus</em>, the adult worms do not form subcutaneous nodules. Eosinophilia is common.</p><p class=\"headingAnchor\" id=\"H4462547\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>M. streptocerca</em> infection should be suspected in an individual with an appropriate epidemiologic exposure, pruritus, a macular hypopigmented rash or lymphadenopathy, <span class=\"nowrap\">and/or</span> unexplained eosinophilia. The definitive diagnosis is established by identifying the microfilariae in the skin. Serology may also be useful.</p><p class=\"headingAnchor\" id=\"H4462554\"><span class=\"h3\">Visualizing organisms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of <em>M. streptocerca</em> infection can be definitively established by detecting microfilariae in skin snips. Reports of adult worms identified in tissue biopsies are extremely few.</p><p>Adult worms are approximately 1.7 cm by 50 mcm for males and 2.7 cm by 85 mcm for females. Microfilariae of <em>M. streptocerca</em> are unsheathed, 180 to 240 mcm long, and have a characteristic sharp curve in the posterior end that is reminiscent of a shepherd's crook (<a href=\"image.htm?imageKey=ID%2F83931\" class=\"graphic graphic_picture graphicRef83931 \">picture 3</a>). This unusual feature allows an experienced technician to distinguish <em>M. streptocerca</em> from <em>O. volvulus</em> microfilariae without special staining.</p><p class=\"headingAnchor\" id=\"H4462561\"><span class=\"h3\">Serology and other tests</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Serologic tests based on crude filarial antigens are positive in <em>M. streptocerca</em> infection but do not distinguish between active or past infection and show cross-reactivity between the different filarial species and with other nematode infections. Consequently, their utility is limited, although a negative result can exclude the possibility of infection.</p><p>Polymerase chain reaction assays have been developed but are not routinely available outside of research laboratories [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/19\" class=\"abstract_t\">19</a>]. Assistance with serologic and other diagnostic tests is available from the United States Centers for Disease Control and Prevention (dpdx@cdc.gov) and the Laboratory of Parasitic Diseases, National Institutes of Health (301-496-5398).</p><p class=\"headingAnchor\" id=\"H942225882\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pruritic rash of <em>M. streptocerca</em> resembles that of onchocerciasis, which is coendemic in many parts of Africa. Nonpruritic hypopigmented lesions seen in onchocerciasis (leopard skin) are smaller than the hypopigmented macules in <em>M. streptocerca</em> infection. Other diseases that must be distinguished include leprosy and tinea. As with the other <em>Mansonella</em> infections, most patients are asymptomatic and are detected incidentally because of eosinophilia. (See <a href=\"topic.htm?path=onchocerciasis\" class=\"medical medical_review\">&quot;Onchocerciasis&quot;</a> and <a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-leprosy\" class=\"medical medical_review\">&quot;Epidemiology, microbiology, clinical manifestations, and diagnosis of leprosy&quot;</a> and <a href=\"topic.htm?path=dermatophyte-tinea-infections\" class=\"medical medical_review\">&quot;Dermatophyte (tinea) infections&quot;</a> and <a href=\"topic.htm?path=approach-to-the-patient-with-unexplained-eosinophilia\" class=\"medical medical_review\">&quot;Approach to the patient with unexplained eosinophilia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4462575\"><span class=\"h2\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=diethylcarbamazine-united-states-available-via-cdc-drug-service-investigational-drug-ind-protocol-only-drug-information\" class=\"drug drug_general\">Diethylcarbamazine</a> (DEC; 6 <span class=\"nowrap\">mg/kg/day</span> for 12 days) is effective for the treatment of <em>M. streptocerca</em> infection and kills both microfilariae and the adult worms, although treatment can be accompanied by exacerbation of clinical symptoms including pruritus, papular eruptions, arthralgias, fever, myalgias, headache, nausea, and vomiting. Furthermore, DEC should not be administered to patients for whom concomitant onchocerciasis cannot be excluded, due to the provocation of serious side effects, including exacerbation of ocular disease. <a href=\"topic.htm?path=ivermectin-drug-information\" class=\"drug drug_general\">Ivermectin</a> (150 <span class=\"nowrap\">mcg/kg</span> as a single dose) is useful in reducing microfilarial loads [<a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/20\" class=\"abstract_t\">20</a>], although the clinical effects of ivermectin in streptocerciasis are unknown. Neither the presence of <em>Wolbachia</em> nor the utility of <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> in the treatment of <em>M. streptocerca</em> have been explored to date.</p><p class=\"headingAnchor\" id=\"H4462582\"><span class=\"h2\">Prevention</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There have been no studies of chemoprophylaxis against <em>M. streptocerca</em> infection. Personal protection measures to limit contact with biting midges may have some utility in individual travelers.</p><p class=\"headingAnchor\" id=\"H4462589\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There are three species of <em>Mansonella</em> that cause human infections: <em>M. streptocerca</em>, <em>M. perstans</em>, and <em>M. ozzardi</em>. <em>Mansonella </em>infections are frequently asymptomatic but may complicate diagnosis and treatment of other human filarial infections that overlap in geographic distribution and clinical manifestations. (See <a href=\"#H4462369\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The epidemiology, clinical manifestations, diagnosis, and treatment vary between <em>Mansonella</em> species and are outlined in the table (<a href=\"image.htm?imageKey=ID%2F66052%7EID%2F70668\" class=\"graphic graphic_table graphicRef66052 graphicRef70668 \">table 1A-B</a>). (See <a href=\"#H4462376\" class=\"local\">'Mansonella perstans'</a> above and <a href=\"#H4462447\" class=\"local\">'Mansonella ozzardi'</a> above and <a href=\"#H4462518\" class=\"local\">'Mansonella streptocerca'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/1\" class=\"nounderline abstract_t\">Simonsen PE, Onapa AW, Asio SM. Mansonella perstans filariasis in Africa. Acta Trop 2011; 120 Suppl 1:S109.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/2\" class=\"nounderline abstract_t\">Marcos LA, Arrospide N, Recuenco S, et al. Genetic characterization of atypical Mansonella (Mansonella) ozzardi microfilariae in human blood samples from northeastern Peru. Am J Trop Med Hyg 2012; 87:491.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/3\" class=\"nounderline abstract_t\">Ta-Tang TH, Luz SL, Merino FJ, et al. Atypical Mansonella ozzardi Microfilariae from an Endemic Area of Brazilian Amazonia. Am J Trop Med Hyg 2016; 95:629.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/4\" class=\"nounderline abstract_t\">Lipner EM, Law MA, Barnett E, et al. Filariasis in travelers presenting to the GeoSentinel Surveillance Network. PLoS Negl Trop Dis 2007; 1:e88.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/5\" class=\"nounderline abstract_t\">Kiefer G, Battegay M, Gyr N, Hatz C. [Mansonella perstans filariasis after stay in Cameroon. A 19-year-old patient born in Cameroon, in Switzerland for the last 10 years]. Praxis (Bern 1994) 2002; 91:61.</a></li><li class=\"breakAll\">Klion A, Nutman TB. Loiasis and Mansonella Infections. In: Tropical Infectious Diseases: Principles, Pathogens and Practice, 3rd ed, Guerrant R, Walker DH, Weller PF (Eds), Saunders Elsevier, Philadelphia 2011. p.735.</li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/7\" class=\"nounderline abstract_t\">Asio SM, Simonsen PE, Onapa AW. Analysis of the 24-h microfilarial periodicity of Mansonella perstans. Parasitol Res 2009; 104:945.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/8\" class=\"nounderline abstract_t\">Keiser PB, Coulibaly Y, Kubofcik J, et al. Molecular identification of Wolbachia from the filarial nematode Mansonella perstans. Mol Biochem Parasitol 2008; 160:123.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/9\" class=\"nounderline abstract_t\">Bregani ER, Rovellini A, Mba&iuml;doum N, Magnini MG. Comparison of different anthelminthic drug regimens against Mansonella perstans filariasis. Trans R Soc Trop Med Hyg 2006; 100:458.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/10\" class=\"nounderline abstract_t\">Coulibaly YI, Dembele B, Diallo AA, et al. A randomized trial of doxycycline for Mansonella perstans infection. N Engl J Med 2009; 361:1448.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/11\" class=\"nounderline abstract_t\">Wanji S, Tayong DB, Layland LE, et al. Update on the distribution of Mansonella perstans in the southern part of Cameroon: influence of ecological factors and mass drug administration with ivermectin. Parasit Vectors 2016; 9:311.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/12\" class=\"nounderline abstract_t\">Nathan MB, Bartholomew CF, Tikasingh ES. The detection of Mansonella ozzardi microfilariae in the skin and blood with a note on the absence of periodicity. Trans R Soc Trop Med Hyg 1978; 72:420.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/13\" class=\"nounderline abstract_t\">Bartoloni A, Cancrini G, Bartalesi F, et al. Mansonella ozzardi infection in Bolivia: prevalence and clinical associations in the Chaco region. Am J Trop Med Hyg 1999; 61:830.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/14\" class=\"nounderline abstract_t\">Vianna LM, Martins M, Cohen MJ, et al. Mansonella ozzardi corneal lesions in the Amazon: a cross-sectional study. BMJ Open 2012; 2.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/15\" class=\"nounderline abstract_t\">Nutman TB, Nash TE, Ottesen EA. Ivermectin in the successful treatment of a patient with Mansonella ozzardi infection. J Infect Dis 1987; 156:662.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/16\" class=\"nounderline abstract_t\">Bartholomew CF, Nathan MB, Tikasingh ES. The failure of diethylcarbamazine in the treatment of Mansonella ozzardi infections. Trans R Soc Trop Med Hyg 1978; 72:423.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/17\" class=\"nounderline abstract_t\">Casiraghi M, Favia G, Cancrini G, et al. Molecular identification of Wolbachia from the filarial nematode Mansonella ozzardi. Parasitol Res 2001; 87:417.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/18\" class=\"nounderline abstract_t\">Fischer P, Bamuhiiga J, B&uuml;ttner DW. Occurrence and diagnosis of Mansonella streptocerca in Uganda. Acta Trop 1997; 63:43.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/19\" class=\"nounderline abstract_t\">Fischer P, B&uuml;ttner DW, Bamuhiiga J, Williams SA. Detection of the filarial parasite Mansonella streptocerca in skin biopsies by a nested polymerase chain reaction-based assay. Am J Trop Med Hyg 1998; 58:816.</a></li><li><a href=\"https://www.uptodate.com/contents/mansonella-infections/abstract/20\" class=\"nounderline abstract_t\">Fischer P, Tukesiga E, B&uuml;ttner DW. Long-term suppression of Mansonella streptocerca microfilariae after treatment with ivermectin. J Infect Dis 1999; 180:1403.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 83819 Version 12.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H4462589\"><span>SUMMARY</span></a></li><li><a href=\"#H4462369\" id=\"outline-link-H4462369\">INTRODUCTION</a></li><li><a href=\"#H4462376\" id=\"outline-link-H4462376\">MANSONELLA PERSTANS</a><ul><li><a href=\"#H4462384\" id=\"outline-link-H4462384\">Epidemiology</a></li><li><a href=\"#H4462398\" id=\"outline-link-H4462398\">Clinical manifestations</a></li><li><a href=\"#H4462405\" id=\"outline-link-H4462405\">Diagnosis</a><ul><li><a href=\"#H4462412\" id=\"outline-link-H4462412\">- Visualizing organisms</a></li><li><a href=\"#H4462419\" id=\"outline-link-H4462419\">- Serology and other tests</a></li></ul></li><li><a href=\"#H942225774\" id=\"outline-link-H942225774\">Differential diagnosis</a></li><li><a href=\"#H4462433\" id=\"outline-link-H4462433\">Treatment</a></li><li><a href=\"#H4462440\" id=\"outline-link-H4462440\">Prevention</a></li></ul></li><li><a href=\"#H4462447\" id=\"outline-link-H4462447\">MANSONELLA OZZARDI</a><ul><li><a href=\"#H4462455\" id=\"outline-link-H4462455\">Epidemiology</a></li><li><a href=\"#H4462469\" id=\"outline-link-H4462469\">Clinical manifestations</a></li><li><a href=\"#H4462476\" id=\"outline-link-H4462476\">Diagnosis</a><ul><li><a href=\"#H4462483\" id=\"outline-link-H4462483\">- Visualizing organisms</a></li><li><a href=\"#H4462490\" id=\"outline-link-H4462490\">- Serology and other tests</a></li></ul></li><li><a href=\"#H942225827\" id=\"outline-link-H942225827\">Differential diagnosis</a></li><li><a href=\"#H4462504\" id=\"outline-link-H4462504\">Treatment</a></li><li><a href=\"#H4462511\" id=\"outline-link-H4462511\">Prevention</a></li></ul></li><li><a href=\"#H4462518\" id=\"outline-link-H4462518\">MANSONELLA STREPTOCERCA</a><ul><li><a href=\"#H4462526\" id=\"outline-link-H4462526\">Epidemiology</a></li><li><a href=\"#H4462540\" id=\"outline-link-H4462540\">Clinical manifestations</a></li><li><a href=\"#H4462547\" id=\"outline-link-H4462547\">Diagnosis</a><ul><li><a href=\"#H4462554\" id=\"outline-link-H4462554\">- Visualizing organisms</a></li><li><a href=\"#H4462561\" id=\"outline-link-H4462561\">- Serology and other tests</a></li></ul></li><li><a href=\"#H942225882\" id=\"outline-link-H942225882\">Differential diagnosis</a></li><li><a href=\"#H4462575\" id=\"outline-link-H4462575\">Treatment</a></li><li><a href=\"#H4462582\" id=\"outline-link-H4462582\">Prevention</a></li></ul></li><li><a href=\"#H4462589\" id=\"outline-link-H4462589\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/83819|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/101816\" class=\"graphic graphic_figure\">- Map Mansonella perstans</a></li><li><a href=\"image.htm?imageKey=ID/101817\" class=\"graphic graphic_figure\">- Map Mansonella streptocerca</a></li><li><a href=\"image.htm?imageKey=ID/82920\" class=\"graphic graphic_figure\">- M perstans lifecycle</a></li><li><a href=\"image.htm?imageKey=ID/83929\" class=\"graphic graphic_figure\">- M ozzardi lifecycle</a></li></ul></li><li><div id=\"ID/83819|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/83928\" class=\"graphic graphic_picture\">- M perstans microfilariae</a></li><li><a href=\"image.htm?imageKey=ID/83930\" class=\"graphic graphic_picture\">- M ozzardi microfilariae</a></li><li><a href=\"image.htm?imageKey=ID/83931\" class=\"graphic graphic_picture\">- M streptocerca microfilariae</a></li></ul></li><li><div id=\"ID/83819|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/66052\" class=\"graphic graphic_table\">- Features of Mansonella spp I</a></li><li><a href=\"image.htm?imageKey=ID/70668\" class=\"graphic graphic_table\">- Features of Mansonella spp II</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-pericarditis-clinical-presentation-and-diagnostic-evaluation\" class=\"medical medical_review\">Acute pericarditis: Clinical presentation and diagnostic evaluation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-patient-with-unexplained-eosinophilia\" class=\"medical medical_review\">Approach to the patient with unexplained eosinophilia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dermatophyte-tinea-infections\" class=\"medical medical_review\">Dermatophyte (tinea) infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing\" class=\"medical medical_review\">Diagnostic evaluation of a pleural effusion in adults: Initial testing</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-leprosy\" class=\"medical medical_review\">Epidemiology, microbiology, clinical manifestations, and diagnosis of leprosy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=loiasis-loa-loa-infection\" class=\"medical medical_review\">Loiasis (Loa loa infection)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lymphatic-filariasis-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Lymphatic filariasis: Epidemiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lymphatic-filariasis-treatment-and-prevention\" class=\"medical medical_review\">Lymphatic filariasis: Treatment and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=new-onset-urticaria\" class=\"medical medical_review\">New-onset urticaria</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=onchocerciasis\" class=\"medical medical_review\">Onchocerciasis</a></li></ul></div></div>","javascript":null}